I now have rich, comprehensive content from multiple authoritative textbooks. I have enough to construct the full teaching module. Let me now compile the definitive answer.
🫀 MYOCARDIAL INFARCTION (MI)
A Complete Exam-Oriented, Clinically Practical Teaching Module
Sources: Robbins & Kumar Pathologic Basis of Disease | Braunwald's Heart Disease | Guyton & Hall Medical Physiology | Ganong's Review of Medical Physiology | Washington Manual of Medical Therapeutics | Goldman-Cecil Medicine | 2025 ACC/AHA Guidelines
1. DEFINITION
One-line exam definition:
Myocardial Infarction is the irreversible death (necrosis) of cardiac muscle caused by prolonged ischemia, most commonly due to occlusion of a coronary artery by atherosclerotic plaque rupture with superimposed thrombosis.
Simple explanation:
Think of the heart as a pump that needs a constant supply of blood. The coronary arteries are its fuel lines. When one of these fuel lines gets blocked (by a clot forming on a ruptured plaque), the heart muscle downstream is starved of oxygen. Within 20-40 minutes, those muscle cells begin to die permanently. That dying zone is the infarct.
Key phrase: "Time is Myocardium" - every minute of delay = more dead muscle.
2. CAUSES (ETIOLOGY)
Common Causes
| Cause | Mechanism | Frequency |
|---|
| Atherosclerotic plaque rupture + thrombosis | Exposes subendothelial collagen → platelet aggregation → thrombus | ~90% |
| Coronary vasospasm (Prinzmetal angina) | Smooth muscle contraction, +/- cocaine or ephedrine | ~5% |
| Coronary embolism | From mural thrombus (AF), endocarditis, prosthetic valve | ~2-3% |
| Small vessel disease | Vasculitis, amyloid, sickle cell disease | Rare |
| Demand ischemia (Type 2 MI) | Severe anemia, tachyarrhythmia, shock | Occasional |
Important Risk Factors
Non-modifiable: Age (males >45y, females >55y), male sex, family history, genetics
Modifiable (Big 6):
- Smoking (most powerful risk factor in young patients)
- Hypertension
- Diabetes mellitus
- Dyslipidemia (high LDL, low HDL)
- Obesity
- Sedentary lifestyle
Important extra: Post-menopausal females lose estrogen protection → IHD becomes the leading cause of death in older women. Hormone replacement therapy does NOT protect and may be pro-thrombotic.
3. TYPES / CLASSIFICATION
A. By ECG Pattern (Most Important Clinically)
| Type | ECG Finding | Pathology | Vessel |
|---|
| STEMI (ST-Elevation MI) | ST elevation + Q waves | Full-thickness (transmural) necrosis | Complete occlusion |
| NSTEMI (Non-ST Elevation MI) | ST depression / T-wave inversion + positive troponin | Subendocardial necrosis | Partial/transient occlusion |
| Unstable Angina (UA) | ST depression / T-wave inversion + negative troponin | Ischemia, no necrosis | Partial occlusion |
STEMI + NSTEMI + UA = collectively called Acute Coronary Syndrome (ACS)
B. By Depth of Necrosis
| Type | Description |
|---|
| Transmural | Full thickness of ventricular wall - causes STEMI; higher complication risk |
| Subendocardial | Inner 1/3 of wall - NSTEMI; subendocardium is most vulnerable (last to receive blood, compressed by systole) |
C. By Universal Classification (for viva)
| Type | Cause |
|---|
| Type 1 | Spontaneous - plaque rupture/erosion |
| Type 2 | Demand ischemia (supply-demand mismatch) |
| Type 3 | Sudden cardiac death before biomarker results |
| Type 4a/b | PCI-related / stent thrombosis |
| Type 5 | CABG-related |
D. By Location
| Artery Occluded | Infarct Location | ECG Leads Affected |
|---|
| LAD (40-50%) | Anterior wall, anterior septum, apex | V1-V4 |
| RCA (30-40%) | Inferior/posterior wall, posterior septum | II, III, aVF |
| LCx (15-20%) | Lateral wall | I, aVL, V5-V6 |
4. PATHOPHYSIOLOGY
Step-by-Step Flowchart
Risk factors (HTN, DM, smoking, dyslipidemia)
↓
Endothelial injury → Atherosclerotic plaque formation in coronary artery
↓
Plaque rupture / erosion (triggered by shear stress, inflammation)
↓
Subendothelial collagen + plaque contents exposed to blood
↓
Platelet adhesion → Activation → Aggregation
(release Thromboxane A2, ADP, serotonin → vasoconstriction + more platelet aggregation)
↓
Coagulation cascade activated (Tissue Factor) → Fibrin clot forms
↓
Coronary artery OCCLUSION (thrombus complete within minutes)
↓
Blood flow ceases to downstream myocardium (area at risk)
↓
Aerobic metabolism STOPS within seconds
→ ATP production falls
→ Creatine phosphate depleted
→ Lactic acid accumulates
↓
Contractility LOST within <2 minutes (stunning begins)
↓
~20-40 minutes: IRREVERSIBLE CELL DEATH begins (necrosis)
(subendocardium first → wavefront progresses outward to epicardium)
↓
Sarcolemmal membrane disruption
→ Intracellular proteins leak into bloodstream
→ Troponin I, Troponin T, CK-MB detected in blood ← BASIS OF BLOOD TESTS
↓
6-12 hours: Necrosis becomes complete
↓
Inflammatory response: Neutrophils → Macrophages → Granulation tissue
↓
2-8 weeks: Fibrous SCAR formation (thin, non-contractile)
↓
Complications: Pump failure, arrhythmia, rupture, aneurysm
Key Biochemical Timeline (from Robbins):
| Event | Time |
|---|
| ATP depletion begins | Seconds |
| Loss of contractility | <2 minutes |
| ATP at 50% of normal | 10 minutes |
| ATP at 10% of normal | 40 minutes |
| Irreversible cell injury | 20-40 minutes |
| Microvascular injury | >1 hour |
| Complete necrosis | 6-12 hours |
Why the Subendocardium Dies First:
The subendocardium is the "perfect victim" - it receives blood last from the epicardial vessels AND is compressed by high intramural pressures during systole, making it most sensitive to any drop in coronary flow.
5. CLINICAL FEATURES
Symptoms
| Symptom | Description | Why It Occurs |
|---|
| Chest pain | Crushing, heavy, tight, "elephant on chest" | Ischemic tissue releases adenosine, bradykinin, histamine → stimulate cardiac pain fibers (C-fibers) |
| Radiation | Left arm, jaw, neck, shoulder, epigastrium | Shared dermatomal pathway (T1-T4) - visceral referred pain |
| Duration | >30 minutes, not relieved by nitrates | Unlike stable angina which resolves <20 min |
| Diaphoresis (sweating) | Cold, clammy sweat | Massive sympathetic activation (catecholamine surge) |
| Breathlessness | Dyspnoea, orthopnoea | LV failure → pulmonary congestion |
| Nausea / Vomiting | Particularly with inferior MI | Vagal activation (RCA supplies AV node + vagal input) |
| Dizziness / Syncope | Light-headedness | Reduced cardiac output |
| Sense of doom | Impending death feeling | Severe sympathetic activation |
Signs
| Sign | What It Means |
|---|
| Pallor, cold clammy skin | Vasoconstriction + reduced output |
| Tachycardia | Compensatory sympathetic activation |
| Bradycardia | Inferior MI - vagal overstimulation |
| Hypotension | Cardiogenic shock, large infarct |
| S4 gallop | Reduced LV compliance (stiff ventricle) |
| S3 gallop | LV failure (large infarct with poor function) |
| Elevated JVP | RV infarction or LV failure |
| Pulmonary crackles (basal) | Pulmonary oedema (LV failure) |
| New murmur | Papillary muscle rupture (MR) or VSD rupture |
Atypical Presentations (High-yield - don't miss!)
- Elderly: Breathlessness alone, confusion, falls
- Diabetics: "Silent MI" - no pain (autonomic neuropathy blunts pain sensation)
- Women: Fatigue, jaw pain, epigastric discomfort - often misdiagnosed
- Inferior MI: Epigastric pain + vomiting - often mistaken for peptic ulcer!
6. KEY SYMPTOMS THAT SUGGEST DIAGNOSIS
Hallmark Symptom
Crushing central chest pain lasting >30 minutes, radiating to the left arm/jaw, NOT relieved by nitrates, accompanied by diaphoresis
Classic Clinical Clues
| Clue | Significance |
|---|
| Pain >30 min, not relieved by rest/nitrates | Distinguishes MI from stable angina |
| Diaphoresis (cold sweat) | Massive sympathetic activation |
| Radiation to jaw/left arm | Classic referred pain |
| Nausea + vomiting | Inferior MI (vagal) |
| New S4 at bedside | Ischemia causing stiff ventricle |
| Epigastric pain in known diabetic | Silent MI, always check ECG + troponin |
Red Flag Findings (Require Immediate Action)
| Red Flag | Indicates |
|---|
| ST elevation on ECG | STEMI → emergency PCI within 90 min |
| New LBBB | Equivalent to STEMI |
| Rising troponin | Active myocardial necrosis |
| Cardiogenic shock | Massive MI (>40% LV loss) |
| New murmur | Mechanical complication (papillary rupture, VSD) |
| Bradycardia + hypotension | RV infarction / complete heart block (inferior MI) |
7. LABORATORY INVESTIGATIONS
| Investigation | Expected Finding | Clinical Significance |
|---|
| Troponin I / T (hs-cTn) | Elevated (rises 3-4h, peaks 12-24h, stays up 7-10 days) | Gold standard biomarker of myocardial necrosis; rise + fall pattern distinguishes MI from other causes |
| CK-MB | Elevated (rises 3-6h, peaks 24h, normalises 48-72h) | Useful for detecting reinfarction (short window); no longer recommended for initial NSTEMI diagnosis |
| LDH (LDH1 > LDH2) | LDH1/LDH2 flip | Used historically; elevated for up to 14 days; useful when patient presents late |
| Myoglobin | Earliest rise (1-2h); nonspecific | First to rise but also elevated in skeletal muscle injury; not cardiac-specific |
| CBC | Leukocytosis (neutrophilia) | Inflammatory response to necrosis; peaks day 2-3; anemia worsens ischemia |
| Blood glucose | Often elevated (stress hyperglycaemia) | Poorer prognosis if elevated; uncontrolled DM increases risk |
| Lipid profile | Total cholesterol, LDL, HDL, TG | Identify and treat dyslipidaemia; note: LDL falsely low acutely - check at admission or after 6 weeks |
| BMP / Renal function | May show renal impairment | Affects drug dosing (heparin, contrast); elevated creatinine = worse prognosis |
| BNP / NT-proBNP | Elevated | Marker of myocardial stress; high BNP = large infarct, urgent angiography |
| Coagulation (PT/INR, aPTT) | Baseline needed | Before anticoagulation/thrombolysis |
| ECG | ST elevation (STEMI), ST depression/T inversion (NSTEMI), Q waves (old MI) | Location of infarct; identifies STEMI for emergency reperfusion |
| Echocardiography (2D Echo) | Regional wall motion abnormality (RWMA), reduced EF | Confirms ischemia; assesses LV function; detects complications (MR, VSD, pericardial effusion) |
| Chest X-ray | Pulmonary oedema, cardiomegaly | Detects pulmonary congestion, excludes pneumothorax/aortic dissection |
| Coronary Angiography | Culprit vessel occlusion | Definitive diagnosis + allows PCI (therapeutic) |
| Cardiac MRI | Infarct size, viability, microvascular obstruction | Not used acutely; useful for viability and prognosis assessment |
Biomarker Timeline (High-Yield Chart)
Hours: 0 2 4 6 12 24 48 72 96 7d 10d 14d
Myoglobin: ——RISE——PEAK——FALL—————————
CK-MB: ———RISE——————PEAK———FALL——————————
Troponin I: ——RISE————————PEAK(24h)————————————————FALL(7-10d)
LDH: ——RISE——————PEAK(3-4d)—————————————FALL(14d)
8. DIFFERENTIAL DIAGNOSIS
| Disease | Similar Features | Differentiating Features |
|---|
| Unstable Angina | Chest pain, ECG changes, risk factors | Troponin NEGATIVE; pain relieved by nitrates; no permanent necrosis |
| Aortic Dissection | Severe chest pain, diaphoresis, may cause MI | Pain is tearing, ripping, radiates to back, unequal BP in arms, wide mediastinum on CXR, no troponin rise early |
| Pulmonary Embolism | Chest pain, dyspnoea, tachycardia | Pleuritic pain (worse on breathing), hypoxia, S1Q3T3 on ECG, D-dimer elevated, CT-PA confirms |
| Pericarditis | Chest pain, ECG changes (ST elevation) | Pain positional (better sitting forward, worse lying), saddle-shaped ST elevation in ALL leads, no Q waves, friction rub, troponin mildly elevated |
| Peptic Ulcer / GORD | Epigastric pain, nausea, vomiting | No ECG changes, no troponin rise, pain related to food, relieved by antacids |
| Oesophageal Spasm | Chest pain, may radiate to arm | No ECG changes, no troponin rise, relieved by nitrates (mimics angina), barium swallow confirms |
| Myocarditis | Chest pain, troponin elevation, ECG changes | Usually young patients, viral prodrome, diffuse ST changes, echo shows global (not regional) dysfunction |
| Pneumothorax | Sudden chest pain, dyspnoea | Absent breath sounds, tracheal deviation, hyperresonance, CXR shows collapsed lung |
9. SHORT CLINICAL CASES
Case 1 - Classic STEMI
"A 58-year-old male smoker with known hypertension presents to the ER with crushing central chest pain of 2 hours duration radiating to the left jaw and arm, associated with profuse sweating and nausea. BP 95/60, HR 108, RR 22. ECG shows 3mm ST elevation in leads II, III, and aVF. Troponin-I is markedly elevated. Pulses are equal bilaterally."
Diagnosis: Inferior STEMI (Right Coronary Artery territory)
Reasoning:
- ST elevation in II, III, aVF = inferior wall = RCA territory
- Classic crushing chest pain >30 min + diaphoresis
- Nausea and bradycardia tendency = vagal activation (inferior MI hallmark)
- Hypotension = may indicate RV involvement or early cardiogenic shock
- Positive troponin = myocardial necrosis confirmed
- Equal BP in both arms = rules out aortic dissection
Action: Activate cath lab - target door-to-balloon time <90 min
Case 2 - NSTEMI / Diabetic Silent Presentation
"A 67-year-old diabetic female presents with a 12-hour history of severe fatigue, mild jaw discomfort, and breathlessness. No obvious chest pain. ECG shows 2mm ST depression in V4-V6. High-sensitivity troponin-T is 0.08 ng/mL (elevated) with a 3-hour repeat of 0.14 ng/mL (significant rise)."
Diagnosis: NSTEMI
Reasoning:
- Atypical presentation (fatigue, jaw pain) - classic in women and diabetics
- No ST elevation → not STEMI; troponin positive → not unstable angina → NSTEMI
- Rising troponin (delta troponin >20% rise) confirms active necrosis
- ST depression in V4-V6 = lateral ischemia
- Diabetic autonomic neuropathy blunts classic chest pain
Action: Antiplatelet therapy + anticoagulation + early invasive strategy within 24h
10. TREATMENT
A. Non-Pharmacological Treatment
- Immediate rest - reduce myocardial oxygen demand
- Oxygen - only if SpO2 <90% (routine oxygen is NOT recommended if SpO2 normal - it causes vasoconstriction)
- IV access - two large-bore cannulas
- Cardiac monitoring - continuous ECG, pulse oximetry
- Reperfusion (the most important treatment):
- Primary PCI (percutaneous coronary intervention) = Drug of Choice for STEMI if available within 120 min (target: door-to-balloon <90 min)
- Thrombolysis (fibrinolytic therapy) = if PCI not available within 120 min (give within 30 min of arrival - "door-to-needle time")
- CABG (coronary artery bypass graft) = for multi-vessel disease, failed PCI, left main disease
- Cardiac rehabilitation after discharge
- Lifestyle modification: Smoking cessation, diet, exercise, weight loss
B. Pharmacological Treatment
| Drug | Drug Group | Mechanism of Action | Indication | Standard Dose | Major Adverse Effects |
|---|
| Aspirin (DOC/First-line) | Antiplatelet (COX-1 inhibitor) | Irreversibly inhibits COX-1 → blocks TXA2 → reduces platelet aggregation | All ACS immediately; continues lifelong | Loading: 300mg PO stat, then 75-100mg OD | GI bleeding, peptic ulcer |
| Clopidogrel | Antiplatelet (P2Y12 blocker) | Irreversibly blocks ADP receptor (P2Y12) on platelets | NSTEMI (if no PCI); with aspirin = DAPT | Loading: 300mg, then 75mg OD | Bleeding; resistance in ~30% (CYP2C19 polymorphism) |
| Ticagrelor (Preferred P2Y12) | Antiplatelet (P2Y12 blocker) | Reversibly blocks P2Y12 receptor | STEMI + NSTEMI with PCI; preferred over clopidogrel | Loading: 180mg, then 90mg BD | Dyspnoea (via adenosine), bleeding; avoid with strong CYP3A4 inhibitors |
| Prasugrel | Antiplatelet (P2Y12 blocker) | Irreversible P2Y12 block (faster onset than clopidogrel) | STEMI with PCI | Loading: 60mg, then 10mg OD | Higher bleeding risk; contraindicated in prior stroke/TIA, age >75y |
| Unfractionated Heparin (UFH) | Anticoagulant | Activates antithrombin III → inhibits thrombin (IIa) and Factor Xa | Acute ACS, during PCI | 60 units/kg IV bolus (max 4000 units) + infusion | Bleeding, HIT (heparin-induced thrombocytopenia) |
| Enoxaparin (LMWH) | Anticoagulant | Primarily inhibits Factor Xa via antithrombin III | NSTEMI/UA; alternative to UFH | 1mg/kg SC BD (reduce to OD if CrCl <30) | Bleeding; less HIT than UFH; not reversible with protamine |
| Morphine | Opioid analgesic | Activates mu-opioid receptors → analgesia + venodilation (reduces preload) | Severe chest pain unresponsive to nitrates | 2-4mg IV, repeat every 5-15 min | Nausea, respiratory depression, hypotension; caution: may delay P2Y12 drug absorption |
| Nitrates (GTN) | Vasodilator | Releases NO → cGMP → smooth muscle relaxation → venodilation (↓ preload) and coronary vasodilation | Chest pain, hypertension; NOT if RV infarction | 0.4mg sublingual, repeat x3; or IV infusion | Headache, hypotension; contraindicated in RV infarction, hypotension, with PDE5 inhibitors |
| Metoprolol / Bisoprolol | Beta-1 blocker | Blocks beta-1 receptors → ↓HR, ↓contractility → ↓oxygen demand; anti-arrhythmic | All MI (start within 24h if stable); continue lifelong | Metoprolol 25-50mg BD PO (IV if hypertensive) | Bradycardia, AV block, bronchospasm; contraindicated in acute HF, bradycardia, severe LV dysfunction |
| ACE Inhibitor (Ramipril/Lisinopril) | ACE Inhibitor | Blocks RAAS → reduces afterload → prevents LV remodelling | All MI, especially with reduced EF or DM; start within 24h | Ramipril 2.5-5mg BD; titrate | Dry cough, hyperkalaemia, renal impairment; contraindicated in bilateral RAS, pregnancy |
| Atorvastatin | HMG-CoA reductase inhibitor (Statin) | Reduces LDL synthesis; stabilises plaques; anti-inflammatory | All ACS - high-intensity statin immediately | 40-80mg OD (high intensity) | Myopathy, hepatotoxicity (rare), elevated LFTs |
| Streptokinase / Alteplase (tPA) | Thrombolytic (Fibrinolytic) | Activates plasminogen → plasmin → dissolves thrombus | STEMI when PCI unavailable within 120 min; give within 12h of symptom onset | Streptokinase 1.5 million units IV over 60 min / Alteplase weight-based | Major bleeding, intracranial haemorrhage (0.5-1%), allergic reaction (streptokinase) |
| Spironolactone / Eplerenone | Aldosterone antagonist | Blocks aldosterone receptor → prevents cardiac fibrosis and remodelling | Post-MI with EF <40% + HF or DM | Eplerenone 25-50mg OD | Hyperkalaemia, gynecomastia (spironolactone) |
Summary - Drug Priority
| Priority | Drug |
|---|
| DOC for reperfusion (STEMI) | Primary PCI (not a drug, but the treatment) |
| DOC for antiplatelets | Aspirin (lifelong) + Ticagrelor (preferred P2Y12 for PCI) |
| DOC for thrombolysis | Alteplase (tPA) if PCI unavailable |
| Emergency analgesic | IV Morphine |
| Emergency vasodilator | Sublingual GTN |
| Long-term prevention | Aspirin + Statin + ACEi + Beta-blocker ("ASAB" mnemonic) |
MONA mnemonic (Emergency Initial Therapy)
M - Morphine (pain relief)
O - Oxygen (if SpO2 <90%)
N - Nitrates (sublingual GTN)
A - Aspirin (300mg chewed)
(+ Add Anticoagulation + P2Y12 inhibitor)
11. CLINICAL PEARLS
Bedside Clues
- A patient with crushing chest pain + diaphoresis + new S4 = MI until proven otherwise
- Inferior MI loves to cause bradycardia and vomiting (vagal effect - RCA supplies SA node + vagal fibers)
- A new pansystolic murmur 2-5 days post-MI = papillary muscle rupture (MR) or VSD - surgical emergency
- RV infarction triad: hypotension + elevated JVP + clear lungs (no pulmonary oedema) - occurs with inferior STEMI; give IV fluids, avoid nitrates!
- Dressler syndrome = pericarditis 2-6 weeks post-MI (immune-mediated) - treat with NSAIDs/aspirin
High-Yield Exam Facts
- Angiography within 4 hours of MI shows thrombosis in 90% of cases
- By 12-24h, thrombosis seen in only 60% (spontaneous lysis occurs)
- 20-40 minutes = window for irreversible damage; beyond 6-12 hours = complete necrosis
- Subendocardium dies FIRST (most vulnerable zone)
- Reperfusion injury causes contraction band necrosis - characteristic microscopically
- Troponin is the GOLD STANDARD biomarker (CK-MB no longer recommended for initial NSTEMI diagnosis)
- LAD occlusion = most common (40-50%), called the "widow maker"
- Q waves on ECG = old/completed infarct (dead electrically silent tissue)
- Wellens syndrome = critical LAD stenosis; biphasic T-waves in V2-V3 even when pain-free - do NOT stress test!
- The 2025 ACC/AHA Guidelines (PMID: 40013746) update STEMI/NSTEMI management with ticagrelor preferred over clopidogrel
Viva Points
- "Why does the subendocardium infarct first?" → Last to receive blood + highest oxygen demand + compressed by systolic pressure
- "What is stunned myocardium?" → Reversible contractile dysfunction after brief ischemia; recovers in days-weeks
- "What is hibernating myocardium?" → Chronically ischemic but viable muscle with reduced function; revascularization restores function
- "Why does LDL appear falsely low in acute MI?" → Acute phase response lowers cholesterol; check lipids at admission or >6 weeks later
- "What is reperfusion injury?" → Paradoxical increase in damage when blood flow is restored; mediated by free radicals, calcium overload, mitochondrial dysfunction
12. COMMON DIAGNOSTIC MISTAKES
| Mistake | Why It Happens | How to Avoid |
|---|
| Missing inferior MI in a "GI" patient | Inferior MI = epigastric pain + vomiting mimics PUD | Always do ECG + troponin in any patient >40y with epigastric pain/vomiting |
| Missing silent MI in diabetics | Autonomic neuropathy - no pain sensation | Low threshold for ECG + troponin in diabetics with fatigue/breathlessness |
| Mistaking pericarditis for STEMI | Both have ST elevation | Pericarditis: saddle-shaped, all leads, no Q waves, positional pain, friction rub, responds to NSAIDs |
| Missing aortic dissection | Both cause severe chest pain | Look for unequal BP in arms, tearing/ripping quality, wide mediastinum; doing thrombolysis in dissection = fatal |
| Giving nitrates in RV infarction | RV depends on preload; nitrates drop preload → severe hypotension | In inferior MI with hypotension + raised JVP + clear lungs → suspect RV MI → give IV fluids, avoid nitrates |
| Ignoring Wellens syndrome | ECG done when pain-free looks "normal" but has biphasic T-waves V2-V3 | Never stress test a Wellens patient - they have critical LAD stenosis; go straight to angiography |
| Falsely reassuring LDL value in acute MI | LDL drops during acute phase response | Always note timing; recheck after 6 weeks or trust admission value |
| Delaying treatment waiting for troponin | Troponin takes 3-4 hours to rise | Treat STEMI on ECG + clinical grounds; don't wait for troponin result to activate cath lab |
13. 5-MINUTE REVISION SUMMARY
DEFINITION
→ Irreversible death of cardiac muscle due to prolonged coronary ischemia
→ ~800,000 cases/year in USA; 1 MI every 40 seconds
CAUSES
→ 90%: Atherosclerotic plaque rupture + coronary thrombosis
→ Risk: Smoking, HTN, DM, Dyslipidaemia, Age, Male sex
→ Rare: Vasospasm, embolism, vasculitis
PATHOPHYSIOLOGY
→ Plaque rupture → Platelet aggregation → Thrombus → Coronary occlusion
→ Ischemia → ATP depleted → Contractility lost (<2 min)
→ Irreversible necrosis at 20-40 min → Complete by 6-12h
→ Subendocardium first; transmural = STEMI; subendocardial = NSTEMI
→ Proteins leak → Troponin detectable in blood (3-4 hours)
SYMPTOMS
→ Crushing central chest pain >30 min, radiates to left arm/jaw
→ Diaphoresis, nausea, breathlessness
→ Silent in diabetics and elderly!
INVESTIGATIONS
→ ECG: ST elevation (STEMI) / ST depression (NSTEMI) / Q waves (old MI)
→ Troponin: Gold standard - rises 3-4h, peaks 24h, stays 7-10 days
→ CK-MB: Useful for reinfarction
→ Echo: Wall motion abnormality (RWMA), assess LV function
→ Coronary angiography: Definitive + therapeutic (PCI)
TREATMENT
Emergency: MONA (Morphine, O2, Nitrates, Aspirin 300mg) + Anticoagulation + P2Y12
Reperfusion: Primary PCI <90 min (door-to-balloon) is DOC
Thrombolysis if PCI unavailable within 120 min
Long-term: Aspirin + Statin (atorvastatin 80mg) + ACEi + Beta-blocker
COMPLICATIONS
Early (hours-days):
→ Arrhythmias - most common cause of EARLY death (VF = #1 killer in first hour)
→ Cardiogenic shock (>40% LV loss)
→ Acute LV failure / pulmonary oedema
→ RV infarction (with inferior MI)
→ Papillary muscle rupture → acute MR (day 2-7)
→ VSD rupture (day 3-5)
→ Free wall rupture (day 5-10) → cardiac tamponade → death
Late (weeks-months):
→ LV aneurysm (persistent ST elevation, risk of mural thrombus/VT)
→ Dressler syndrome (autoimmune pericarditis, 2-6 weeks)
→ Heart failure (chronic)
→ Reinfarction
Recent Evidence Update (2025): The
2025 ACC/AHA Guideline for Acute Coronary Syndromes reinforces primary PCI as the gold standard, updates antiplatelet strategies (ticagrelor preferred over clopidogrel for most PCI patients), and refines risk stratification for NSTEMI management. A 2025 Lancet meta-analysis (PMID: 40902613) also revisited clopidogrel vs aspirin for long-term secondary prevention.
Sources consulted: Robbins & Kumar Pathologic Basis of Disease (9780443264528) | Guyton & Hall Medical Physiology (9780443111013) | Ganong's Review of Medical Physiology (9781260122404) | Washington Manual of Medical Therapeutics (9781975190620) | Braunwald's Heart Disease (9780323722193) | 2025 ACC/AHA ACS Guidelines (PMID: 40013746)